Drugs / IMOVAC-POLIO
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02775942 Comparator | Nov 2015 → Jul 2016 | poliomyelitis | National Institute of Hygiene and Epidemiology, Vietnam | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IMOVAC-POLIO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02775942 ↗ |
| Modality | Vaccine | “licensed vaccine (IMOVAC-Sanofi Pasteur- France)” NCT02775942 ↗ |
| Route | Subcutaneous | “Subcutaneous route 0.5ml/dose” NCT02775942 ↗ |